311 related articles for article (PubMed ID: 15151933)
21. Dietary phytoestrogens accelerate the time of vaginal opening in immature CD-1 mice.
Thigpen JE; Haseman JK; Saunders HE; Setchell KD; Grant MG; Forsythe DB
Comp Med; 2003 Dec; 53(6):607-15. PubMed ID: 14727808
[TBL] [Abstract][Full Text] [Related]
22. Effects of chronic genistein treatment in mammary gland, uterus, and vagina.
Rimoldi G; Christoffel J; Seidlova-Wuttke D; Jarry H; Wuttke W
Environ Health Perspect; 2007 Dec; 115 Suppl 1(Suppl 1):62-8. PubMed ID: 18174952
[TBL] [Abstract][Full Text] [Related]
23. Reproductive safety studies with genistein in rats.
McClain RM; Wolz E; Davidovich A; Edwards J; Bausch J
Food Chem Toxicol; 2007 Aug; 45(8):1319-32. PubMed ID: 17433519
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
[TBL] [Abstract][Full Text] [Related]
25. Estrogenic isoflavones in rodent diets.
Degen GH; Janning P; Diel P; Bolt HM
Toxicol Lett; 2002 Mar; 128(1-3):145-57. PubMed ID: 11869825
[TBL] [Abstract][Full Text] [Related]
26. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.
Mathey J; Mardon J; Fokialakis N; Puel C; Kati-Coulibaly S; Mitakou S; Bennetau-Pelissero C; Lamothe V; Davicco MJ; Lebecque P; Horcajada MN; Coxam V
Osteoporos Int; 2007 May; 18(5):671-9. PubMed ID: 17333448
[TBL] [Abstract][Full Text] [Related]
27. Enhanced estrogenic responses and sensitivity to azoxymethane following dietary soy isoflavone supplementation in older female rats.
Daly KT; Tracy AC; Malik M; Wang T; Francke-Carroll S; Magnuson BA
Food Chem Toxicol; 2007 Apr; 45(4):628-37. PubMed ID: 17157426
[TBL] [Abstract][Full Text] [Related]
28. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.
Muthyala RS; Ju YH; Sheng S; Williams LD; Doerge DR; Katzenellenbogen BS; Helferich WG; Katzenellenbogen JA
Bioorg Med Chem; 2004 Mar; 12(6):1559-67. PubMed ID: 15018930
[TBL] [Abstract][Full Text] [Related]
29. Effects of lactational exposure to soy isoflavones on reproductive system in neonatal female rats.
Liu Z; Zhang X; Li L; Zhang W; Cui W; Song Y; Wang W; Jia X; Li N; Yan W
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):317-24. PubMed ID: 18047477
[TBL] [Abstract][Full Text] [Related]
30. Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries.
Jackman KA; Woodman OL; Chrissobolis S; Sobey CG
Brain Res; 2007 Apr; 1141():99-107. PubMed ID: 17274967
[TBL] [Abstract][Full Text] [Related]
31. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; Johannes WU; Miller GJ
Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
[TBL] [Abstract][Full Text] [Related]
32. The impact of dietary organic and transgenic soy on the reproductive system of female adult rat.
Brasil FB; Soares LL; Faria TS; Boaventura GT; Sampaio FJ; Ramos CF
Anat Rec (Hoboken); 2009 Apr; 292(4):587-94. PubMed ID: 19301281
[TBL] [Abstract][Full Text] [Related]
33. Effects of dietary equol administration on ovariectomy induced bone loss in Sprague-Dawley rats.
Rachoń D; Seidlová-Wuttke D; Vortherms T; Wuttke W
Maturitas; 2007 Nov; 58(3):308-15. PubMed ID: 17961939
[TBL] [Abstract][Full Text] [Related]
34. Morphologic changes induced by oral long-term treatment with 8-prenylnaringenin in the uterus, vagina, and mammary gland of castrated rats.
Rimoldi G; Christoffel J; Wuttke W
Menopause; 2006; 13(4):669-77. PubMed ID: 16837889
[TBL] [Abstract][Full Text] [Related]
35. Estrogenic activity of bovine milk high or low in equol using immature mouse uterotrophic responses and an estrogen receptor transactivation assay.
Nielsen TS; Nørgaard JV; Purup S; Fretté XC; Bonefeld-Jørgensen EC
Cancer Epidemiol; 2009 Jul; 33(1):61-8. PubMed ID: 19679050
[TBL] [Abstract][Full Text] [Related]
36. Neuromodulation by soy diets or equol: anti-depressive & anti-obesity-like influences, age- & hormone-dependent effects.
Blake C; Fabick KM; Setchell KD; Lund TD; Lephart ED
BMC Neurosci; 2011 Mar; 12():28. PubMed ID: 21410981
[TBL] [Abstract][Full Text] [Related]
37. Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production.
Vergne S; Titier K; Bernard V; Asselineau J; Durand M; Lamothe V; Potier M; Perez P; Demotes-Mainard J; Chantre P; Moore N; Bennetau-Pelissero C; Sauvant P
J Pharm Biomed Anal; 2007 Mar; 43(4):1488-94. PubMed ID: 17110073
[TBL] [Abstract][Full Text] [Related]
38. Reproductive toxicity assessment of chronic dietary exposure to soy isoflavones in male rats.
Faqi AS; Johnson WD; Morrissey RL; McCormick DL
Reprod Toxicol; 2004 Jun; 18(4):605-11. PubMed ID: 15135855
[TBL] [Abstract][Full Text] [Related]
39. Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism.
Cederroth CR; Vinciguerra M; Gjinovci A; Kühne F; Klein M; Cederroth M; Caille D; Suter M; Neumann D; James RW; Doerge DR; Wallimann T; Meda P; Foti M; Rohner-Jeanrenaud F; Vassalli JD; Nef S
Diabetes; 2008 May; 57(5):1176-85. PubMed ID: 18420492
[TBL] [Abstract][Full Text] [Related]
40. The soy isoflavone genistein decreases adipose deposition in mice.
Naaz A; Yellayi S; Zakroczymski MA; Bunick D; Doerge DR; Lubahn DB; Helferich WG; Cooke PS
Endocrinology; 2003 Aug; 144(8):3315-20. PubMed ID: 12865308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
